Chapman Financial Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Chapman Financial Group's ELV Position: Q1 2026 in Review
Chapman Financial Group reduced its Elevance Health (ELV) stake by 4.4% in Q1 2026, selling an estimated $13.1K and leaving 877 shares worth $257K. The position accounts for 0.18% of the portfolio, ranked #111.
Chapman Financial Group first reported a position in ELV in Q4 2024 and has held it in 5 quarters since. The position peaked at $809K in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Chapman Financial Group held 877 shares of Elevance Health worth $257K as of Q1 2026.
- Chapman Financial Group sold 40 Elevance Health shares in Q1 2026, an estimated $13.1K.
- Elevance Health made up 0.18% of Chapman Financial Group's portfolio in Q1 2026, its #111 holding.
- Chapman Financial Group first reported a position in Elevance Health in Q4 2024 and has held it in 5 quarters since.
- Chapman Financial Group's Elevance Health position peaked at $809K in Q2 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Chapman Financial Group's 13F filing for Q1 2026, filed 12 May 2026.